Last reviewed · How we verify

NCT06670430

Digital Heath Integration With Neuromodulation Therapies on Diabetic Neuropathy

Recruiting now NA Last updated 1 November 2024
What this trial tests

NA trial testing experimental group in Diabetic Neuropathies in 60 participants. Currently enrolling.

Timeline
10 November 2024
Primary endpoint
30 August 2025
30 December 2025

Quick facts

Lead sponsorCairo University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment60
Start date10 November 2024
Primary completion30 August 2025
Estimated completion30 December 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 55 to 65, any sex, with Diabetic Neuropathies. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be carried out on 60 patients both gender male and female with diabetic neuropathy with age55-65 years. The patients will be selected from Elmahmoudia hospital .patients will be randomly assigned to two groups.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of experimental group

Trials testing the same drug.

Other recruiting trials for Diabetic Neuropathies

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06670430.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing